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A striking feature of Burkholderia contaminans strain MS14 is the production of a glycolipopeptide named
occidiofungin. Occidiofungin has a broad range of antifungal activities against plant and animal pathogens. In
this study, a complete covalent structure characterization and identification of the whole genomic DNA region
for the occidiofungin gene (ocf) cluster are described. Discovery of the presence of 2,4-diaminobutyric acid and
3-chloro--hydroxytyrosine and elucidation of the structure of a novel C18 fatty amino acid residue have been
achieved. In addition, seven additional putative open reading frames (the genes from ocfI to ocfN [ocfI-N] and
ORF16) were identified. Transcription of all the putative genes ocfI-N identified in the region except ORF16
was regulated by both ambR1 and ambR2. Elucidation of the structure and the ocf gene cluster provides insight
into the biosynthesis of occidiofungin and promotes future aims at understanding the biosynthetic machinery.
This work provides new avenues for optimizing the production and synthesis of structural analogs of
occidiofungin.
Burkholderia contaminans strain MS14, showing a broad
range of antifungal activities against plant and animal patho-
gens, was isolated from a disease-suppressive soil (24). A
45.2-kb genomic DNA fragment harboring 11 open reading
frames (ORFs), including the biosynthetase genes and two
LuxR regulatory genes, ambR1 and ambR2 (13, 14), was iden-
tified. Analysis of transcription demonstrated that both ambR1
and ambR2 are essential for the expression of all the ORFs
except for ORF1 and the antifungal activity. Production of a
glycolipopeptide, named occidiofungin, is responsible for the
antifungal activities of strain MS14 (22). Initial structural char-
acterization of occidiofungin revealed two variants, occidiofun-
gin A and occidiofungin B. Both are composed of 8 amino
acids (aa), differing by an addition of oxygen to occidiofungin
B forming a -hydroxy asparagine. The two structurally related
antifungal compounds have masses of 1,119.5 and 1,215.5 Da.
Nonribosomal peptide synthetase (NRPS) and polyketide
synthetase (PKS) are large multimodular enzymes which are
involved in natural product synthesis in many microorganisms
(5). NRPS, involved in the biosynthesis of oligopeptide, is
grouped by active sites termed modules, in which each module
is required for catalyzing one single cycle of product length
elongation. The order and number of the modules of an NRPS
protein are mainly determined by the “collinearity rule” (12).
There are three main domains in each module: the adenylation
(A) domain, responsible for amino acid recognition; the thio-
lation (T) domain, which is the carrier of thioesterified amino
acid intermediates; and the condensation (C) domain, which
catalyzes peptide bond formation between two consecutive
amino acids (5). The epimerization (E) domain as one of the
modification domains catalyzes the conversion of L-amino ac-
ids to their D-isomers (26). Cyclization and release of the
peptide product are catalyzed by the C-terminal thioesterase
(TE) domain (36). Polyketide synthetases are a family of en-
zymes or enzyme complexes that produce polyketides, a large
class of secondary metabolites, in bacteria, fungi, plants, and a
few animal lineages (17). The biosynthesis of polyketides
shares striking architectural and organizational similarities
with nonribosomal peptide biosynthesis, and their modules can
be integrated to produce the hybrid NRPS-PKS products.
Some pharmaceutical antimicrobial agents, such as the precur-
sor of penicillin and erythromycin, are synthesized through
these mechanisms (6, 7, 32, 40).
Burkholderia bacteria, which are widely distributed in na-
ture, are reported to be important for plant growth promotion
(4). However, taxonomic distinctions have not enabled biolog-
ical control strains to be clearly distinguished from human
pathogenic strains, which has led to the reassessment of the
risk of the registered Burkholderia strains as biological control
agents (27). For example, some strains of B. contaminans were
isolated from sputum and blood samples of debilitated patients
such as cystic fibrosis patients (42), while other strains have
shown significant antifungal activities (13). Analysis of the ge-
netic elements and molecular mechanisms in Burkholderia may
benefit the development of biologically based management
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approaches while potentially providing means to eliminate the
deleterious effects of the microorganism. In this paper, we
describe a genomic region that contributes to biosynthesis of
occidiofungin, as well as the structure of the unique antifungal
compound.
The whole genomic sequences of 22 strains of Burkholderia
determined to date are available in the NCBI database (http:
//www.ncbi.nlm.nih.gov/genomes/lproks.cgi). According to the
annotation of the ExPASy Proteomics Server, eight of them
are human pathogens, including three strains of Burkholderia
cenocepacia, three strains of Burkholderia pseudomallei, and
two strains of Burkholderia mallei. B. cenocepacia is an oppor-
tunistic pathogen of human cystic fibrosis or chronic granulo-
matous diseases (25). B. pseudomallei and B. mallei are the
causal agents of melioidosis and glanders diseases, respectively
(3, 15). The other 12 strains, such as Burkholderia lata strain
383, were not considered to be human pathogens (http://www
.expasy.ch/sprot/hamap/BURM1.html).
In this study, the right border of the ocf gene cluster was
sequenced, and further sequence analysis revealed the pres-
ence of another seven additional ORFs, which include ocfJ,
another NRPS gene, and ocfN, a putative thioesterase gene.
Nuclear magnetic resonance (NMR), mass spectrometry, and
amino analysis data have helped to resolve regions of struc-
tural uncertainty. We have clarified the structure of a novel
amino acid and identified the presence of a chloro--hydroxy-
tyrosine (chloro-BHY) and 2,4-diaminobutyric acid (DABA).
Characterization of the covalent structure and elucidation of
the gene cluster provide a solid basis for modeling the biosyn-
thesis of the unique antifungal compound, as well as provide
avenues for improving the yield of occidiofungin during fer-
mentation.
MATERIALS AND METHODS
NMR spectroscopy. Occidiofungin was produced and purified as previously
described (13). A 3.5-mg sample of occidiofungin was dissolved in 600 l of
dimethyl sulfoxide (DMSO-d6; Cambridge Isotopes). The NMR data were col-
lected on a Bruker Avance DRX spectrometer, equipped with a CryoProbe,
operating at a proton frequency of 600 MHz. The 1H resonances were assigned
according to standard methods (45) using correlation spectroscopy (COSY),
total correlation spectroscopy (TOCSY), and nuclear Overhauser effect spec-
troscopy (NOESY) experiments. Rotating-frame Overhauser enhancement spec-
troscopy (ROESY) and 13C-heteronuclear single quantum correlation (HSQC)
experiments were used to clarify some areas of ambiguity in the TOCSY and
NOESY spectra. NMR experiments were collected at 25°C. The carrier fre-
quency was centered on the residual water resonance (3.333 ppm), which was
suppressed minimally using standard presaturation methods. A 2.0-s relaxation
delay was used between scans. The TOCSY experiment was acquired with a
60-ms mixing time using the Bruker DIPSI-2 spinlock sequence. The NOESY
and ROESY experiments were acquired with 400-ms mixing times. The param-
eters for collecting the HSQC spectrum were optimized to observe aliphatic and
aromatic CH groups. The spectral sweep width for the TOCSY, NOESY, and
ROESY was 11.35 ppm in both dimensions. The spectral sweep widths for
HSQC were 11.35 ppm in the proton dimensions and 100 and 150 ppm for the
carbon dimension. All two-dimensional (2D) data were collected with 2,048
complex points in the acquisition dimension and 256 complex points for the
indirect dimensions, except for the HSQC, which was collected with 2,048 and
128 complex points in the direct and indirect dimensions, respectively. Phase-
sensitive indirect detection for NOESY, ROESY, TOCSY, and COSY experi-
ments was achieved using the standard Bruker pulse sequences. 1H chemical
shifts were referenced to the residual water peak (3.33 ppm). Data were pro-
cessed with nmrPipe (8) by first removing the residual water signal by deconvo-
lution, multiplying the data in both dimensions by a squared sinebell function
with 45- or 60-degree shifts (for the 1H dimension of HSQC), zerofilling once,
Fourier transformation, and baseline correction. Data were analyzed with the
interactive computer program NMRView (16). The NOE cross-peak intensities
were measured in NMRView. Distances were calibrated using the relationship
rab
6  rcal
6(Vcal/Vab), where rab is the distance between atoms a and b, Vab is the
NOESY a to b cross-peak volume, rcal is a known distance, and Vcal is the
corresponding volume of the NOESY calibration cross-peak. The distance used
for calibrations was the distance between the -hydroxy Tyr4 H and Hε aromatic
protons (2.46 Å).
Mass spectrometry. Occidiofungin (10 g) was evaporated to dryness in a
Speed Vac concentrator (ThermoScientific, San Jose, CA), and the residue was
taken up in 50 l methanol and analyzed by direct infusion at 3 l/min into an
LCQ DecaXP (ThermoScientific, San Jose, CA) operated with a capillary volt-
age of 20 V, a spray voltage of 3,000 V, and a capillary temperature of 150°C.
Data were acquired for 3 min over a mass range of m/z 200 to 2,000.
Amino acid analysis. Amino acid analysis was performed at the Molecular
Structure Facility, UC Davis. This facility uses a “post-ion-exchange column”
ninhydrin reaction detection system. Amino acid analysis was also performed at
the Texas A&M Protein Chemistry Lab by using a Hewlett Packard AminoQuant
II system. Occidiofungin samples were aliquoted, mixed with internal standards
(norvaline [Int1], sarcosine [Int2], and 2,4-diaminobutyrate [DABA]), dried in
glass tubes in a vacuum concentrator, and subjected to vapor phase hydrolysis.
The samples were subsequently reconstituted in 0.4 N borate buffer to bring the
pH to 10 for optimum derivatization. Primary amino acids tagged with o-phthal-
dialdehyde (OPA) were detected by the diode array (UV) detector at 338/390
nm, and the fluorometric detector monitored the primaries at excitation/emis-
sion wavelengths of 340/450 nm. Precolumn derivatized amino acids were eluted
from a narrow-bore 5-m reverse-phase column.
Bacterial strains, plasmids, and culture conditions. The bacterial strains and
plasmids used in this study are described in Table 1. Escherichia coli strain JM109
was grown in Luria-Bertani medium at 37°C (35). Burkholderia strains were
cultured at 28°C on nutrient broth-yeast (NBY) extract agar medium (43). When
required, antibiotics were added at the following concentrations: ampicillin (100
g ml1), trimethoprim (50 g ml1), chloramphenicol (12.5 g ml1), and
kanamycin (100 g ml1 for E. coli and 300 g ml1 for the MS14 mutants).
Random mutagenesis, genomic library screening, and sequencing. To identify
more genes associated with production of antifungal compound of strain MS14,
the mutant MS14MT24 (Table 1) was generated and plasmid pSL604 was ob-
tained using an EZ-Tn5 R6Kori/KAN-2Tnp Transposome kit (Epicentre
Biotechnologies, Madison, WI) as described previously (13). Fosmid 4G5 was
identified from the MS14 genomic library using the 1-kb PCR product from
pSL604 as described previously (13). The DNA insert of fosmid 4G5 was se-
quenced using a random shotgun approach (37). At least triple coverage of
sequencing reactions was achieved, and the Lasergene software package
(DNASTAR, Inc., Madison, WI) was used for generation of a consensus se-
quence. Open reading frames (ORFs) and genes were subsequently predicted by
the Softberry FGENESB program (Softberry, Inc., Mount Kisco, NY), and the
identified ORFs and genes were analyzed using Blastx in the NCBI database.
Putative promoter sequences were identified by the Softberry BPROM program.
The InterProScan program was used for prediction of functional domains of
proteins (33). NRPSpredictor (34) and the NRPS-PKS web-based software (2)
were used for specificity prediction of adenylation domains in nonribosomal
peptide synthetases (NRPSs). The program IslandPick was used to analyze the
sequence characteristics as genomic islands (19).
Site-directed mutagenesis and complementation of the ocfJ gene. The wild-
type ocfJ gene was disrupted by the insertion of a kanamycin cassette into its
open reading frame as described previously (23). To mutate ocfJ, the 4-kb
fragment obtained by PCR using primers MoccEF and MoccER (see Table S1 in
the supplemental material) was cloned into the pGEM-T Easy Vector System I
(Promega Corporation, Madison, WI), resulting in plasmid pGG20. The nptII
gene (1) was inserted into pGG20 at BamHI, generating plasmid pGG21. The
5-kb EcoRI fragment of pGG21 harboring the ocfJ gene disrupted by insertion
of nptII was cloned into pBR325 (31) at the EcoRI site to generate pGG22.
Mutagenesis of the ocfJ gene was conducted via a marker exchange procedure as
described previously (23), to generate the mutant MS14GG78 (Table 1). PCR
analysis and sequencing were used to verify the double crossover mutations.
To obtain the intact wild-type gene ocfJ, which was disrupted in the mutant
MS14GG78, a 4.5-kb fragment was amplified by PCR using primers EoccEF2
and EoccER2 (see Table S1 in the supplemental material), both of which contain
the HindIII site (Table S1), and cloned into the pGEM-T Easy vector, resulting
in the plasmid pGG23. The presence of the intact ocfJ gene in the 4.5-kb DNA
fragment was verified by sequencing. The 4.5-kb HindIII fragment harboring the
intact ocfJ gene was inserted into the Burkholderia gene expression vector pMLS7
(21), to generate the plasmid pGG24. The plasmid pGG24 was electroporated
into cells of the mutant MS14GG78, an ocfJ mutant (Table 1). Colonies acquir-
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ing trimethoprim resistance were confirmed to contain the plasmid construct
pGG24 by plasmid extraction and restriction enzyme digestion. Complementa-
tion experiments were conducted using the plate assays to evaluate antifungal
activity against Geotrichum candidum as described previously (13).
RNA extraction and quantitative real-time PCR. Total RNA of strain MS14
and its mutants was extracted using an RNeasy Protect bacteria kit (Qiagen,
Valencia, CA) as recommended by the manufacturer. Transcription of the ORFs
and genes was analyzed using quantitative real-time PCR (Q-PCR) as described
previously (12, 13). Primers for Q-PCR are described in the supplemental data
(see Table S1 in the supplemental material). Three replicates of Q-PCR were
conducted independently, and statistically significant differences were deter-
mined for relative quantity (RQ) values by analysis of variance (ANOVA; P 
0.05) followed by the Bonferroni and Dunnett post hoc multiple comparisons
(SAS Institute, Inc., NC).
Nucleotide sequence accession number. A 58.1-kb genomic DNA fragment,
named the ocf gene cluster, was obtained and deposited into GenBank with the
accession number EU938698.
RESULTS AND DISCUSSION
Occidiofungin contains nonproteinogenic amino acids. The
covalent structure of occidiofungin was determined to contain
a -hydroxy modification of asparagine (BHN), a -hydroxy
modification of tyrosine (BHY), and a 3-chloro addition to
-hydroxytyrosine (chloro-BHY), as well as a novel amino acid
(NAA) derived from fatty acid synthesis (Fig. 1). Expansion of
the TOCSY 2D NMR spectra showing the amide to alpha and
the amide to side chain spin systems for each assigned residue
in occidiofungin is shown in Fig. 2. Chemical shift values are
provided in the supplemental data (see Table S2 in the sup-
plemental material). Observed interresidue NOEs are summa-
rized in Fig. S1 in the supplemental material, and an expansion
of the NOESY spectra showing interresidue NOEs is also
shown in the supplemental data (see Fig. S2 and S3).
Initial structural characterization was done using an aqueous
solvent (50% acetonitrile-d3 [ACN]–50% water) and limited
NMR experiments that provided a preliminary understanding
of the antifungal compound structure (22). In these analyses,
the antifungal peptide was determined to be an eight-residue
cyclic glycolipopeptide via amide to alpha and amide to amide
proton sequential walk along the backbone atoms. Further-
more, the compound was determined to contain a xylose at-
tached to a novel amino acid. Further analyses using a non-
aqueous solvent, along with additional NMR experiments,
provided means to refine the structural predictions. In this
TABLE 1. Bacterial strains and plasmids
Strain or plasmid Relevant characteristicsa Source orreference
Escherichia coli JM109 recA1 endA1 gyrA96 thi hsdR17 supE44 relA1 	(lac-proAB)/F
 traD36 proAB lacIq lacZ	M15 Promega
Burkholderia contaminans
MS14 Wild-type strain 13
MS14MT15 ambR2::Tn5 derivative of MS14; Kmr 13
MS14GG44 ambR1::nptII derivative of MS14; Kmr 14
MS14MT24 ocfH::Tn5 derivative of MS14; Kmr This study
MS14GG78 ocfJ::nptII derivative of MS14; Kmr This study
Plasmid/fosmid
pSL604 EZ-Tn5 carrying the 1-kb genomic DNA of MS14MT24; Kmr This study
pBluescript II SK Cloning vector; Apr Stratagene
pBR325 Cloning vector; Cmr Tcr Apr 31
pMLS7 Expression vector of Burkholderia; Tpr 21
pGEM-T Easy Cloning vector; Apr Promega
pBSL15 Kanamycin resistance gene cassette; Kmr 1
pGG20 pGEM-T Easy carrying 4-kb PCR product containing the ocfJ gene; Apr This study
pGG21 pGG20 with the nptII insertion in ocfJ at the BamHI site; Kmr Apr This study
pGG22 pBR325 carrying the 5-kb EcoRI fragment containing ocfJ gene disrupted by nptII; Cmr Tcr Kmr This study
pGG23 pGEM-T Easy carrying 4.5-kb PCR product containing the intact ocfJ gene; Apr This study
pGG24 pMLS7 carrying 4.5-kb HindIII fragment harboring the intact ocfJ gene; Tpr This study
4G5 pCC1FOS carrying 40-kb genomic DNA of MS14; Cmr This study
a Kmr, kanamycin resistance; Apr, ampicillin resistance; Tpr, trimethoprim resistance; Cmr, chloramphenicol resistance; Tcr, tetracycline resistance.
FIG. 1. Covalent structure of occidiofungin. (A) Monoisotopic
masses for each variant, occidiofungins A to D, are provided, along
with the location of each variance, designated by R1 and R2. (B) Rep-
resentative circle diagram of the covalent structure of occidiofungin.
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study, we have determined that position 2 is a C18 glyco-amino
acid, position 3 is a serine, position 4 is a mixture of BHY and
chloro-BHY, and position 5 is a 2,4-diaminobutyric acid
(DABA).
To help elucidate the structure of NAA2, COSY NMR spec-
tra were collected to sequentially assign proton couplings
within this residue. An almost complete sequential walk for the
proton couplings could be observed in the COSY data set for
NAA2 (see Fig. S4 in the supplemental material), providing
evidence that the novel amino acid is a C18 fatty acid residue,
similar to what has been reported for cepacidine (20). The only
break in the proton coupling occurs between C-8 and C-9,
which is visible in the TOCSY data set. The attachment site for
the xylose sugar was determined to be at the C-7 position (Fig.
3; see Fig. S5 in the supplemental material). C-5, C-6, and C-7
all have chemical shift values supporting the presence of an
oxygen in their vicinity and could support the attachment of
the xylose. However, C-5 and C-6 have a correlation to a
hydroxyl proton, while C-7 lacks a correlation to a proton on a
hydroxyl, thus supporting an ether linkage to the sugar. In
addition, NOEs are observed between the proton on C-7 and
C-8 of NAA2 and the proton on C-1 of the xylose sugar.
The chemical shift values that were found along the amide
frequency for the amino acid at position 3 could account for
only a few amino acids, many of which could be ruled out based
on their absence in the amino acid analysis (AAA) data. AAA
revealed the presence of asparagine, glycine, serine, and lysine
in the molecule (see Fig. S6 in the supplemental material). The
beta proton chemical shift values (3.27 ppm) for the residue
at position 3 are out of the normal range for a serine (3.88
ppm). The proximity of the tyrosine ring presumably shields
the beta proton on Ser3, causing a lower-than-predicted chem-
ical shift (3.88 ppm), which accounts for the Ser -proton
chemical shifts of 3.27 ppm (see Table S2 in the supplemental
material). Further examination of the NMR data sets revealed
that coupling between the beta protons to the hydroxyl proton
of Ser3 could be seen (see Fig. S7 in the supplemental mate-
rial), further supporting the assignment of a serine at this
position.
Indole-like resonances in the NMR TOCSY and NOESY
data sets were identified. A peak at 10.03 ppm (see Fig. S8 in
the supplemental material), which corresponds to the fre-
quency of an indole epsilon proton, was observed. In addition,
the characteristic indole proton frequencies were also observed
in the aromatic region of the TOCSY spectra. These reso-
nances were characteristic of a tryptophan residue. Additional
NMR data were collected to determine the location and struc-
ture of the indole-like residue in the compound. Aromatic
HSQC data revealed the presence of three additional proton
carbon couplings, which is one less than expected for an indole
ring (Fig. 4A). Mass spectrometry data helped to characterize
the nature of this residue. Electrospray ionization (ESI) mass
spectrometry data revealed the existence of four structural
variants of the antifungal peptide, one with a mass [M  1 (H)]
of 1,200.39 Da, one with a mass of 1,216.41 Da, one with a mass
of 1,234.17 Da, and the fourth having a mass of 1,250.41 Da,
which corresponds to the addition of oxygen and/or chlorine to
the first compound (Fig. 4B). These masses are in accordance
with the elucidated structure (calculated monoisotopic masses
of 1,199.592, 1,215.587, 1,233.553, and 1,249.548 Da) shown in
Fig. 1. Natural abundance of chlorine isotope 35 and 37 exists
in a 3:1 ratio, which helps to confirm chlorination. As shown in
Fig. 4B (peaks labeled with a, b, and c), the relative abundance
for each isotope of a nonhalogenated compound will have a
typical stair step pattern for M  1, M  2, and M  3, while
the chlorinated compound (peaks labeled with x, y, and z) will
have an increase in the M 3 isotope. The increase in the M
3 isotope is due to the addition of 37Cl. The identification of a
chlorination taking place in the molecule helped clarify the
FIG. 2. Expansion of the TOCSY 2D NMR spectra showing the
amide to alpha and amide to side chain spin systems for each assigned
residue in occidiofungin. Horizontal lines show the multiple amide
proton chemical shift values for each amino acid.
FIG. 3. Covalent structure of novel amino acid 2. The proton
chemical shift values (in ppm) are shown next to their respective
atoms. NOE values (in gray) are written next to the circles, and arrows
designate the proton interactions. The thick lines between the atoms
represent proton couplings observed in the COSY 2D NMR data set.
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nature of the other aromatic residue observed in the NMR
data. The three additional proton carbon couplings observed in
the aromatic HSQC data are actually resonances for C-2, C-5,
and C-6 of the BHY ring, and the chlorination of the tyrosine
ring occurs at the C-3 position. The addition of the chlorine to
the C-3 ring position is responsible for the observed downfield
shift of the hydroxyl proton of Tyr to 10.03 ppm and is respon-
sible for the downfield shift of the other aromatic protons. The
presence of three distinct proton resonances on the aromatic
ring for chloro-BHY4, instead of two proton resonances for
BHY4, arises from the chlorination at the C-3 position, causing
the environments for the protons at position C-2, C-5, and C-6
to be chemically distinct. The presence of these four structural
variances is similar to what has been reported for the nonri-
bosomally synthesized antibiotics balhimycin and vancomycin
(6, 44). Furthermore, the presence of four structural variants
of occidiofungin explains the multiple amide proton chemical
shift values observed for each amino acid residue (Fig. 2).
Further analysis of the COSY data set revealed that the
proton couplings of the predicted lysine at position 5 (predic-
tion based on AAA data) did not match this assignment. Al-
ternatively, the residue appeared to be a 2,4-diaminobutyric
acid. This was unexpected given the identification of Lys by
amino acid analysis (see Fig. S6A in the supplemental mate-
rial). Possibly, as was previously shown, lysine and 2,4-di-
aminobutyric acid may have the same retention time when
ion-exchange chromatography is used to separate amino acids
using a “post-column” ninhydrin reaction detection system.
Therefore, an alternative method was used along with a DABA
standard. Following acid hydrolysis, high-performance liquid
chromatography (HPLC) separation followed by UV detection
(UV) and fluorescent detection (FLD) was used to see if we
could distinguish a DABA from a lysine. Using this method, we
did not see a lysine, but we did observe a concomitant increase
in the glycine-to-serine volume ratio (Fig. S6B). An internally
loaded standard of DABA (5 nm) was shown to coelute with
glycine using this procedure (Fig. S6C). The amino acid anal-
ysis data are in agreement with the NMR data supporting the
assignment of a DABA at position 5.
As described above, an extensive amount of new data has
been analyzed providing a definitive assignment of the struc-
ture of occidiofungin. The assignment of the fatty glyco-amino
acid at position 2 and the serine at position 3 and the presence
of a -hydroxytyrosine and a 3-chloro--hydroxytyrosine at
position 4 and 2,4-diaminobutyric acid at position 5 satisfy all
chemical shifts present in the NMR data sets, ESI mass spec-
trometry data, and amino acid analysis data. Furthermore, our
structure is in agreement with the genetic data in the ocf gene
cluster.
The ocf gene cluster. Seven new ORFs (the genes from ocfI
to ocfN [ocfI-N] and ORF16) were identified (Fig. 5; Table 2)
upstream of the 45.2-kb genomic fragment that was previously
reported (14). This region was sequenced through the sequenc-
ing of the fosmid 4G5. A 58.1-kb genomic DNA fragment,
named the ocf gene cluster, was obtained and deposited into
GenBank.
Sequence analysis revealed that the ocf gene cluster, exclud-
ing ORF1 and ORF16, shares high similarity (99% nucleotide
coverage and 91% identity) to an uncharacterized DNA region
of Burkholderia ambifaria strain AMMD, which was used for
biological control of plant diseases (28). The gene cluster was
not found in other Burkholderia strains or any other strains
available in GenBank (nucleotide coverage, 24%), including
some identified opportunistic human pathogens: B. cenocepa-
cia strains J2315, AU1054, and HI2424, B. pseudomallei strains
668, 1710b, and 1106a, and B. mallei strains NCTC 10247 and
NCTC 10229. The sequences of the flanking regions of the ocf
gene cluster in strain MS14 share highest identities (89% nu-
cleotide identity) with the homologs C7522 (left) and C7511
(right) in chromosome 3 of B. lata 383. The average GC
content of the ocf gene cluster is 67.74%, which is closer to
those of flanking region sequences in strain AMMD (left:
bam_6475, 68.5%; right: bam_6483, 65.89%) but different from
those of strain MS14 (55.16% left and 61.81% right). Besides,
sequence analysis using the program IslandPick indicated that
the uncharacterized exclusive homolog of the ocf gene cluster
in strain AMMD possesses the characteristics of a genomic
island. These data suggest that the ocf gene cluster may have
been horizontally transferred from a strain similar to B. ambi-
faria AMMD and had integrated into a strain similar to B. lata
383. More importantly, the absence of the gene cluster in
clinical strains of Burkholderia suggests that the gene cluster is
not required for potential human pathogenesis and presum-
ably is not involved in pathogenesis. This finding has provided
FIG. 4. Identification of a chloro-BHY. (A) Expansion of the HSQC 2D NMR spectra shows the proton and carbon chemical shift values for
the chloro-BHY and BHY. (B) ESI mass spectrometry data show the presence of four variants differing in mass by the addition of an oxygen and
chlorine. a, b, and c show a typical stair step pattern for each isotope, while x, y, and z show an increase in the M  3 isotope corresponding to
the addition of 37Cl.
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insights for the usage of the gene cluster for engineering bio-
control agents for agricultural use. Furthermore, a detailed
understanding of the gene cluster provides avenues for improv-
ing the production of occidiofungin, thus promoting studies
aimed at understanding the compound’s therapeutic potential.
Organization and orientations of the genes ocfI-N are the
same as those of the B. ambifaria strain AMMD genome, with
an average amino acid identity of 91%, and ORF16 has the
highest similarity (93%) to its homolog C7511 of B. lata strain
383 (Fig. 5; Table 2), while its homolog was not found in the
genome of the strain AMMD with BLAST. The putative pro-
tein (1,107 aa) from ocfI was predicted to encode a hybrid
monooxygenase-PKS. The gene ocfJ was predicted to encode
an NRPS (1,475 aa). The genes ocfK, ocfL, and ocfM were
predicted to encode oxygenase or halogenase, transaminase,
and an epimerase or dehydratase, respectively (Table 2). The
putative protein sequence of ocfN is 219 aa in length and
carries a TE domain. Putative promoters were identified up-
stream of ORF1, ambR1, ocfL, and ORF16, and their locations
are shown in Fig. 5.
Disruption of the NRPS gene ocfJ eliminated the antifungal
activity of strain MS14. A nonpolar mutation was con-
structed by insertion of an nptII cassette into BamHI of ocfJ,
and the mutant MS14GG78 was generated by marker ex-
change mutagenesis. PCR analysis demonstrated that ocfJ
was disrupted by insertion of nptII in the genome of the
mutant. The mutant exhibited negligible antifungal activity
toward G. candidum (inhibitory zone radius  standard
error of the mean [SEM], 0.33  0.33 mm), which is similar
to results for the mutants MS14MT13, MS14MT18 (13),
MS14MT16 (14), and MS14MT24 (see Fig. S9 in the sup-
plemental material). As expected, the wild-type strain MS14
showed a strong inhibition against the fungus (13.00  0.58
mm). The wild-type level of antifungal activities against G.
candidum was observed for MS14GG78 complemented in
trans with plasmid pGG24 (12.67  0.33 mm). As expected,
FIG. 5. Map of the 58.1-kb occidiofungin gene cluster region of Burkholderia contaminans strain MS14. The positions and orientations of the
known genes and potential ORFs are shown as horizontal arrows. Vertical arrows and flags indicate the insertion positions of the Tn5 transposon
and the nptII gene cassette, respectively. The open and solid vertical arrows/flags represent reduction and elimination of antifungal activity,
respectively. The arrows indicate putative promoter sequences. The genotypes of the MS14 mutants are GG44(ambR1::nptII), MT15(ambR2::Tn5),
MT13(ocfD::Tn5), MT18(ocfE::Tn5), MT14(ocfH::Tn5), MT16(ocfH::Tn5), and GG78(ocfJ::nptII).
TABLE 2. Putative genes identifieda
Gene or ORF Size (bp) Homologb Identity (%) Predicted functionc
ORF1 (partial) 1,175 bamb_6465 93 FAD-linked oxidase domain protein
ambR1 822 bamb_6466 89 LuxR-type regulator
ambR2 891 bamb_6468 77 LuxR-type regulator
ocfA 1,704 bamb_6469 90 Cyclic peptide transporter
ocfB 483 bamb_6470 82 Hypothetic protein
ocfC 657 bamb_6471 94 Glycosyl transferase
ocfD 9,495 bamb_6472 88 NRPS
ocfE 9,066 bamb_6473 89 NRPS
ocfF 3,921 bamb_6474 90 NRPS
ocfG 1,617 bamb_6475 93 Hydroxylase
ocfH 13,410 bamb_6476 91 Hybrid NRPS-PKS
ocfI 3,324 bamb_6477 92 Flavin-dependent monooxygenase
ocfJ 4,428 bamb_6478 91 NRPS
ocfK 987 bamb_6479 91 Halogenase
ocfL 1,371 bamb_6480 91 Transaminase
ocfM 951 bamb_6481 94 Epimerase
ocfN 720 bamb_6482 90 Thioesterase
ORF16 288 C7511 93 Conserved hypothetical proteind
a The shaded gray region represents previously published work (13, 14). Annotations of a 12.9-kb genomic DNA fragment upstream of ocfH are not shaded.
b Homolog to the putative proteins of Burkholderia ambifaria AMMD (GenBank accession no. NC_008392).
c Predicted functions are based on annotation of strain AMMD and strain 383.
d Homolog to C7511 of B. lata 383 (GenBank accession no. NC_007509).
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the presence of the empty vector pMLS7 had no effect on
antifungal activities of either the wild-type strain MS14 or
the mutant MS14GG78 (data not shown). These results
further confirmed the essential role of the ocf gene cluster in
the production of antifungal activity of strain MS14.
Transcription of ocfI-N but not ORF16 was regulated by
both ambR1 and ambR2, the LuxR-type regulatory genes. To
test the relationship between the newly identified genes or
ORFs with the LuxR regulatory genes ambR1 and ambR2,
Q-PCR analyses were performed with RNAs isolated from
strain MS14 and the mutants MS14GG44 and MS14MT15.
Previous studies demonstrated that both ambR1 and ambR2
positively regulated transcription of ocfA-H (14). As expected,
significant differences (P  0.05) of expression levels of ocfI-N
in the mutants MS14GG44 and MS14MT15 were observed
compared with those in the wild-type strain MS14. Transcript
levels of the genes in mutants MS14GG44 and MS14MT15,
with mutations in LuxR-type regulatory genes, were reduced
13.2- and 12.0-fold, respectively (Fig. 6). These data suggest
that transcription of ocfI-N is promoted by both the ambR1
and ambR2 genes.
Transcription of ORF16 was not significantly affected by
the mutations in either ambR1 or ambR2, indicating that the
ORF16 is not regulated by either of them. In addition, the
ORF16 gene, which codes for a hypothetically conserved pro-
tein, has highest identity (93%) to the protein encoded by ORF
C7511 of B. lata strain 383; however, no significant homolog
was found in the genome of strain AMMD, which has an
uncharacterized genomic region sharing the highest similarity
to the ocf gene cluster (ambR1 to ocfN). These data imply that
ORF16, similar to ORF1 (14), may not be part of the gene
cluster required for the antifungal activity of strain MS14.
Therefore, ocfN is most likely the last gene at the right border
of the gene cluster, while ambR1 is the first gene at the left
border of the gene cluster. These results indicate that the
whole length of the ocf gene cluster responsible for the pro-
duction of occidiofungin has been identified (Fig. 5).
In summary, the whole length of the ocf gene cluster has
been characterized, which is composed of 16 ORFs. Among
the 16 members of this cluster, ocfD, ocfE, ocfF, ocfH, and ocfJ
were predicted to encode NRPS or NRPS-PKS and are di-
rectly related to the biosynthesis of the antifungal compound
occidiofungin. The genes ocfC, ocfK, ocfL, ocfM, and ocfN
were predicted to be involved in the modification of occidio-
fungin or its components. AmbR1 and AmbR2 are the regu-
lators controlling the transcription and expression of occidio-
fungin. The predicted functions of the ocf gene cluster are
basically in agreement with the covalent structure.
Occidiofungin biosynthesis. Completion of the sequencing
of the ocf gene cluster and the completion of the detailed
structural characterization of occidiofungin provides an excel-
lent opportunity to model the biosynthesis of occidiofungin
(Fig. 7). Gene products required for the synthesis of the novel
amino acid are all located in the ocf gene cluster (Fig. 5). The
order in which the modules function, so that they are in agree-
ment with the structure, is as follows: OcfJ-OcfI-OcfH-OcfF-
OcfE-OcfD. Through NRPS-PKS web-based software and in-
terProScan software in EMBL-EBI, the predicted domains in
these modules are A-T-KS (ketosynthase; OcfJ) FDM (flavin-
dependent monooxygenase)-KS-T (OcfI) KS-AT (acyl trans-
ferase)-KR (ketoreductase)-T-KS-AT-T-AmT (aminotransfer-
ase)-C-A-T-C (OcfH) A-T-E (OcfF) C-A-T-E-C-A-T-C
(OcfE) A-T-C-A-T-E-C-T-Te (OcfD). These predictions are
in agreement with the structural analyses of occidiofungin.
The ocfJ gene encodes a hybrid NRPS-PKS peptide contain-
ing domains characteristic of both NRPSs and PKSs. As de-
scribed above, the potential domains are A-T-KS. There is no
AT domain to accompany the KS domain in ORF11. There-
fore, it is possible that OcfJ functions solely as an NRPS. This
NRPS domain is presumably important for the addition of
Asn1/BHN1 to NAA2. Evidence for this assumption comes
from the lack of a C domain, which can occur in the first
module of NRPS (9). A condensation module is present in
OcfH, which can join Asn1/BHN1 to NAA2.
Based on interProScan and NRPS-PKS web-based software
predictions described above, the ocfH gene has the following
domains: KS-KR-T-AT-T-AmT-C-A-T-C. OcfH has the char-
acteristics of a hybrid PKS-NRPS and is presumably responsi-
ble for the partial synthesis of NAA2. The ketoreductase do-
main is likely to be involved in the oxidation of the carbonyl
ketones on the fatty amino acid-forming alcohols, while the
aminotransferase domain is likely to be involved in the trans-
fers of an amino group to C-3 of the fatty acid forming a fatty
amino acid. ocfC, ocfI, and ocfM are also predicted to be
involved in the synthesis of NAA2. C-5, C-6, and C-7 all carry
a hydroxyl group. The presence of a hydroxyl group on C-5 and
FIG. 6. Expression of the ORFs identified in the ocf gene cluster in strain MS14 and its mutants MS14MT15 and MS14GG44 (Table 1).
Transcript levels of the tested genes and ORFs are presented relative to the transcript levels in the wild-type MS14. Mean values for three
biological replicates are given, and error bars represent the standard errors of the means.
VOL. 77, 2011 MAP OF OCCIDIOFUNGIN OF B. CONTAMINANS MS14 6195
 o
n
 Septem
ber 11, 2018 by guest
http://aem
.asm
.org/
D
ow
nloaded from
 
C-7 could arise from the reduction of the ketone by the ke-
toreductase present in OcfH during fatty acid synthesis. The
hydroxyl group on C-6 requires an independent hydroxylation.
OcfI has a flavin-dependent monooxygenase domain which
may be responsible for the addition of the hydroxyl group to
C-6 (29). OcfC and OcfM are presumably important for the
addition of xylose to C-7. OcfM codes for a homolog of a
NAD-dependent epimerase/dehydratase called UDP-D-gluc-
uronate 4-epimerase (39). This enzyme is involved in convert-
ing UDP-glucuronate to UDP-xylose. The ocfC gene codes for
the putative glycosyl transferase and is predicted to catalyze
the transfer of a xylose to C-7, forming the glyco-amino acid
(Fig. 3; see Fig. S5 in the supplemental material). There was no
predicted dehydratase domain, which is needed for the subse-
quent removal of the hydroxyl groups from the polyketide
chain (from C8 to C18 carbons) forming the fatty acid chain
observed in the NMR data. Presumably, this activity is being
harnessed from fatty acid biosynthesis or possibly OcfB, a
hypothetical protein. However, gene knockout and comple-
mentation experiments should provide confirmation of the
function of this gene product.
By use of the NRPS-PKS web-based software, the C-ter-
minal part of OcfH is predicted to catalyze the addition of
Ser, and it has an identity of 54% and similarity of 67% to
the other NRPS domains that catalyze addition of Ser.
Therefore, it is predicted that the NRPS adds a serine to the
Asn-NAA2 product. Subsequently, OcfF is predicted to be
responsible for the addition of the BHY to the Asn/BHN1-
NAA2-Ser3 product. The NRPS-PKS web-based software
predicts OcfF to catalyze the addition of Tyr, and this pro-
FIG. 7. Representative diagram for the biosynthesis of occidiofungin. Some steps are demarcated with an asterisk, indicating the high potential
of alternative routes of synthesis in the model. For instance, it is conceivable that glycosylation can occur before the synthesis of the peptide. In
addition, no homology exists in the database for the proposed dehydratase activity of OcfB, and this activity may be attributed to another gene
outside the gene cluster.
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tein has 38% identity and 55% similarity to those responsi-
ble for Tyr addition.
There were no confirmed modular predictions for OcfE
using the NRPS-PKS web-based software. The two modules
are predicted to catalyze the addition of DABA5 to the Asn/
BHN1-NAA2-Ser3-BHY4 product and subsequently add Gly6
to the Asn/BHN1-NAA2-Ser3-BHY4-DABA5 product. The
NRPS-PKS web-based software predicts that OcfD catalyzes
the addition of Asn and Ser. Therefore, the first module would
add an Asn to the Asn1/BHN1-NAA2-Ser3-BHY4-DABA5-
Gly6 product, and the second module would add a Ser to the
Asn/BHN1-NAA2-Ser3-BHY4-DABA5-Gly6-Asn7 product.
The gene ocfL, predicted to code an -ketoglutarate 4-ami-
notransferase, is presumably responsible for the transfers of an
amino group during the biosynthesis of DABA (41). Substrates
are predicted to be L-glutamate and L-aspartate, and the re-
sulting products would be L-2,4-diaminobutyric acid and L--
ketoglutarate. The ocfG gene encodes a homolog of an enzyme
known to be involved in the formation of -hydroxytyrosine,
StaM of the A47934 cluster (30). This enzyme oxidizes the beta
carbon, while Tyr is tethered to the T domain. It is likely that
the enzyme is responsible for the beta-hydroxylations of Tyr4
and Asn1. Given the presence of Asn and BHN at position 1,
it is likely that the hydoxylation of Asn on the T domain of
module 1 is inefficient. Based on the structural predictions
presented above, three of the eight modules in the ocf gene
cluster harbor an internal E-domain for the conversion of L to
D isomers. Therefore, it is likely that BHY4, DABA5, and Ser8
residues in occidiofungin are D form.
The C-terminal region of OcfD is predicted to have a TE
domain, which is presumably important for the condensation
reaction of Ser8 to Asn/BHN1, which terminates synthesis and
forms the cyclic peptide. The ocfN gene also codes for a thio-
esterase. Given that the N-terminal end of the linear peptide is
an Asn or BHN, it is possible that two thioesterases are re-
quired to form the Asn and BHN structural variants of the
cyclic peptide.
The gene ocfA is predicted to encode an ATP-binding cas-
sette (ABC) transporter. This large superfamily of integral
membrane proteins are known to carry various substrates
across cellular membranes. Given that it is regulated by ambR1
and ambR2, this is presumably the transporter for effective
secretion of the antifungal compound. The ocfK gene codes for
a homolog of nonheme iron dioxygenases that can catalyze
oxidations, as well as chlorinations (30). Potentially this en-
zyme catalyzes the chlorination that is observed on BHY. An-
other possibility is that the halogenase activity is attributed to
another gene outside the ocf gene cluster. In Fig. 7, the chlo-
rination event is arbitrarily shown to occur at the end. Previous
studies have shown that chlorination takes place sometime
during peptide synthesis (32).
The genetic information of the ocf gene cluster, along with
the covalent structure, has provided a solid foundation to en-
gineer strains that will enhance the production of occidiofun-
gin and to engineer new chemical variants with increased an-
tifungal activity, while minimizing possible toxicity to plants
and animals. For example, overexpression of ocfA and/or
ambR1 (regulator) may increase occidiofungin production by
strain MS14. The study of hybrid NRPS-PK natural products,
which further expands the perspective of combinatorial biosyn-
thesis, is attracting more attention (11). Some hybrid products
with medicinal importance have been reported, such as rapa-
mycin, bleomycin, and leinamycin (10, 18, 38). Understanding
the genetic structures for the production of occidiofungin, es-
pecially the biosynthesis of the novel amino acid, will benefit
the optimization and production of novel products.
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